EFNA5 (ephrin A5)
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
1946 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Ephrin A5 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
EFNA5 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS |
Chromosome
Chromosome number
|
5 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
5q21.3 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | |||||||||||
UniProt ID | P52803 | ||||||||||
Protein name | Ephrin-A5 (AL-1) (EPH-related receptor tyrosine kinase ligand 7) (LERK-7) | ||||||||||
Protein function | Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on ad | ||||||||||
PDB | 2X11 , 3MX0 , 4BK5 , 4BKA , 4L0P , 4M4R | ||||||||||
Family and domains |
Pfam
|
||||||||||
Sequence |
|
||||||||||
Sequence length | 228 | ||||||||||
Interactions | View interactions |
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|
Associated diseases
Disease information provided by ClinVar, GenCC, and GWAS databases.
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|